Category Archives: Mesenchymal Stem Cells

THE Davao Adventist Hospital is now offering services for autologous stem cell therapy. Marketing officer Kim Endrei Go said the therapy is the first in Davao City and an alternative treatment for degenerative diseases of joints and bones caused by sports injuries and chronic pains. Go said the treatment allows the patient to continue the normal routine even after the treatment. He said the therapy is non-surgical and has a healing period of only three days. The modalities in extracting stem cells in the therapy are either through the Platelet Rich Plasma (PRP) and through Bone Marrow Aspiration Concentrate. Go said autologous means that the stem cells will be extracted from the patient himself and will be regenerated through an equipment. The hospital uses the Harvest technologies from the United States which introduced the SmartPrePtm2. SmartPrePtm2 is used to redefine platelet concentrate systems. Its latest innovation will further expand and enhance the use of autologous bioactive proteins as well as help optimize the condition for healing. Go said that the therapy session depends on the severeness of the patient's condition. He added that most patients had 3 sessions but some had once or twice. He said the technology was first … Continue reading →

Tucson, AZ and San Juan Capistrano, CA (PRWEB) May 29, 2013 Liposuction.com, the largest website dedicated to liposuction education, and AdiCyte, the nations leading cryobank for adipose [fat] derived tissue and stem cells, have partnered to educate consumers about StemCellLipo and the value of banking adipose tissue and stem cells following liposuction. StemCellLipo is a new add-on procedure that enables liposuction patients to collect and preserve their youngest stem cells for use in the future in regenerative medicine or tissue engineering. Oddly, fat is the largest source of mesenchymal stem cells [MSC] in the human body. These stem cells can replicate into other types of cells such as bone, nerve, cartilage and muscle. Doctors have already successfully regenerated knee cartilage in arthritic patients, and engineered new blood vessels and whole organs such as a bladder, using a patients own MSCs. Since regenerative medicine with MSCs is the focus of over 100 clinical trials for things like recovery after a heart attack and spinal disc regeneration, banking the cells has been referred to as a type of biological insurance in case of future need. We think http://www.liposuction.com is the quintessential online resource for patients interested in liposuction and every single one … Continue reading →

Christian Jngst 3D live cell imaging of the adipogenic differentiation of mesenchymal stem cells By: Andor Technology … Continue reading →

India, May 26 -- The All India Institute of Medical Sciences (AIIMS) is set to advance stem cell research for Multiple Sclerosis (MS), a disease that attacks the central nervous system. "A proposal will soon be sent to the Stem Cell Ethics Committee at the hospital to conduct both epidemiological and therapeutic study using conventional drugs and studies related to stem cell therapy for the disease," said Dr Rohit Bhatia, additional professor of neurology at AIIMS. A proposal for hematopoietic stem cell transplant has already been submitted for ethics clearance and for mesenchymal stem cell therapy. The proposal will be soon sent for clearance and funding. "We have proposed a therapeutic study for multiple sclerosis which involves removing the cells with stem cells that repopulate the body to treat the abnormality due to expansion of autoreactive cells," said Dr Kameshwar Prasad, Professor of Neurology, AIIMS. Though it is know that multiple sclerosis is common among people from temperate or colder climes, a study conducted by AIIMS showed that such cases were increasing in India as well. According to the study, of 101 patients at the hospital between June 2011 to December 2012, it was proved that ratio of female patients … Continue reading →

Stem Cell Therapy Worldwide http://www.placidway.com/ - Looking for best and affordable stem cell therapy? Placidway offers best and most affordable stem cell therapy with the top docto... By: placidways's channel … Continue reading →

The case against stem cell osteoarthritis treatment http://www.stemcellsarthritistreatment.com Stem cells are associated with several problems. First, self-renewal and plasticity are useful properties when it ... By: Nathan Wei … Continue reading →

San Diego, CA (PRWEB) May 20, 2013 Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert L. Wilensky, MD, Professor of Medicine and Director of Interventional Cardiology Research at the University of Pennsylvania has agreed to join the Scientific and Medical Advisory Board for Stemedicas Cardiology Division. At the University of Pennsylvania, Dr. Wilensky divides his time between the cardiac catheterization laboratories and the translational animal laboratory. His research interests include acute coronary syndromes, diagnosis and treatment of vulnerable coronary lesions and stem cell therapy for decreased left ventricular function and coronary artery disease. Stephen Epstein, MD, Chairman of Stemedicas Cardiology Division Scientific and Medical Advisory Board commented, Dr. Wilenskys strong interest and expertise in both interventional cardiology and translational medicine, most notably with stem cells, parallels and strongly supports the direction we are taking with Stemedica. Dr. Wilensky received his MD degree with distinction from the University of Amsterdam. His internship and residency in Internal Medicine was obtained at the Georgetown University Medical Center in Washington, DC. His fellowship in Cardiology was at the Krannert Institute of Cardiology, Indiana University, where he was Chief Fellow and later Assistant Professor … Continue reading →

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, the University of Southern California, on Monday, May 20, 2013. Dr. Wests presentation titled Derivation of chondrogenic progenitor lines from human embryonic stem cells is scheduled for 8:30 am PDT. Dr. West will describe BioTimes novel and proprietary PureStemTM technology which allows the industrial scale-up of over 200 different human cell types in a highly purified state from human embryonic stem cells. In addition, Dr. West will present new data on purified and scalable human embryonic progenitors with molecular markers corresponding to limb bud mesenchyme and will show differentiation data on those corresponding to the developing leg. These novel cells differ markedly from adult mesenchymal stem cells and may have novel applications in limb regeneration and the repair of disease and injuries to the weight-bearing joints. The presentation will be made available on BioTime's website at http://www.biotimeinc.com, and Dr. West discusses the cells in his weekly video update available for viewing … Continue reading →

Dr. Tom Reh on Stem Cell Therapy http://www.fightblindness.org | Thomas Reh, Ph.D, of the University of Washington, discusses how stem cell therapy, a term for using stem cells to treat and prevent... By: FndFightingBlindness … Continue reading →

What is Stromal Vascular Fraction (SVF)? Learn more about the Cell Surgical Network and the process of Stromal Vascular Fraction (SVF). The Cell Surgical Network: NonEmbryonic Adult Stem Cells Adult... By: CellSurgicalNetwork … Continue reading →